Targeting pathogen metabolism without collateral damage to the host

Abstract excerpt

The development of drugs that can inactivate disease-causing cells (e.g. cancer cells or parasites) without causing collateral damage to healthy or to host cells is complicated by the fact that many proteins are very similar between organisms. Nevertheless, due to subtle, quantitative differences between the biochemical reaction networks of target cell and host, a drug can limit the flux of the same essential...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biochemical Acid Research Studies
• Share to Microbial Metabolic Engineering and Bioproduction
• Share to Trypanosoma species research and implications